AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-96
Results: 1-25/96

Authors: DENARDO GL DENARDO SJ LAMBORN KR GOLDSTEIN DS LEVY NB LEWIS JP OGRADY LF RAVENTOS A KROGER LA MACEY DJ MCGAHAN JP MILLS SL SHEN S
Citation: Gl. Denardo et al., LOW-DOSE, FRACTIONATED RADIOIMMUNOTHERAPY FOR B-CELL MALIGNANCIES USING I-131 LYM-1 ANTIBODY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 239-254

Authors: DENARDO SJ KROGER LA MACKENZIE MR MIRICK GR SHEN S DENARDO GL
Citation: Sj. Denardo et al., PROLONGED SURVIVAL ASSOCIATED WITH IMMUNE-RESPONSE IN A PATIENT TREATED WITH LYM-1 MOUSE MONOCLONAL-ANTIBODY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 1-12

Authors: DENARDO GL DENARDO SJ KROGER LA GOLDSTEIN DS LAMBORN KR SHEN S ODONNELL RT
Citation: Gl. Denardo et al., MILESTONES IN THE DEVELOPMENT OF LYM-1 RADIOIMMUNOTHERAPY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 44-44

Authors: DENARDO GL KROGER LA MEARES CF RICHMAN CM SALAKO Q SHEN S LAMBORN KR PETERSON JJ MIERS LA ZHONG GR DENARDO SJ
Citation: Gl. Denardo et al., COMPARISON OF 10-TETRAAZACYCLODODECANE-N,N',N'',N'''-TETRAACETIC ACID(DOTA)-PEPTIDE-CHL6, A NOVEL IMMUNOCONJUGATE WITH CATABOLIZABLE LINKER, TO 2-IMINOTHIOLANE-2 [P-(BROMOACETAMIDO)BENZYL]-DOTA-CHL6 IN BREAST-CANCER XENOGRAFTS, Clinical cancer research, 4(10), 1998, pp. 2483-2490

Authors: SHEN S TSAI WY LEUNG R STRONG E WONG P LOUGHLIN KR ROBBINS PW GASTON SM
Citation: S. Shen et al., GLCNACTV GENE INTERACTIONS - USE OF YEAST 2 HYBRID TECHNOLOGY TO IDENTIFY PROTEINS IN PROSTATE TISSUES AND IN LNCAP THAT BIND GLCNACTV, Glycobiology, 8(11), 1998, pp. 154-154

Authors: DENARDO GL DENARDO SJ GOLDSTEIN DS KROGER LA LAMBORN KR LEVY NB MCGAHAN JP SALAKO Q SHEN S LEWIS JP
Citation: Gl. Denardo et al., MAXIMUM-TOLERATED DOSE, TOXICITY, AND EFFICACY OF I-131 LYM-1 ANTIBODY FOR FRACTIONATED RADIOIMMUNOTHERAPY OF NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 16(10), 1998, pp. 3246-3256

Authors: DENARDO GL SHEN S DENARDO SJ LIAO SQ LAMBORN KR DENARDO DA YUAN A
Citation: Gl. Denardo et al., QUANTIFICATION OF I-131 IN TUMORS USING A THRESHOLD BASED ON IMAGE-CONTRAST, European journal of nuclear medicine, 25(5), 1998, pp. 497-502

Authors: DENARDO GL DENARDO SJ KUKIS DL ODONNELL RT SHEN S GOLDSTEIN DS KROGER LA SALAKO Q DENARDO DA MIRICK GR MAUSNER LF SRIVASTAVA SC MEARES CF
Citation: Gl. Denardo et al., MAXIMUM TOLERATED DOSE OF CU-67-2IT-BAT-LYM-1 FOR FRACTIONATED RADIOIMMUNOTHERAPY OF NON-HODGKINS-LYMPHOMA - A PILOT-STUDY, Anticancer research, 18(4B), 1998, pp. 2779-2788

Authors: SHEN S DENARDO GL JONES TD WILDER RB ODONNELL RT DENARDO SJ
Citation: S. Shen et al., A PRELIMINARY CELL-KINETICS MODEL OF THROMBOCYTOPENIA AFTER RADIOIMMUNOTHERAPY, The Journal of nuclear medicine, 39(7), 1998, pp. 1223-1229

Authors: DENARDO GL DENARDO SJ DENARDO DA SHEN S MIRICK GR MACEY DJ LAMBORN KR
Citation: Gl. Denardo et al., FACTORS AFFECTING I-131 LYM-1 PHARMACOKINETICS AND RADIATION-DOSIMETRY IN PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL) AND CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL), The Journal of nuclear medicine, 39(5), 1998, pp. 438-438

Authors: DENARDO SJ SHEN S KROGER LA MIERS LA RICHMAN CM KUKIS DL SALAKO Q MEARES CF DENARDO GL
Citation: Sj. Denardo et al., EVIDENCE IN MICE AND PATIENTS THAT A NOVEL PEPTIDE LINKED Y-90 DOTA-CHIMERIC L6 IMMUNOCONJUGATE DECREASED HEPATIC RADIATION-DOSE, The Journal of nuclear medicine, 39(5), 1998, pp. 833-833

Authors: SHEN S DENARDO GL YUAN A ODONNELL RT DENARDO SJ
Citation: S. Shen et al., SPLENIC VOLUME, PATIENT-SPECIFIC DOSIMETRY AND THERAPEUTIC RESPONSE FOR PATIENTS TREATED USING RADIOIMMUNOTHERAPY (RIT), The Journal of nuclear medicine, 39(5), 1998, pp. 839-839

Authors: DENARDO SJ RICHMAN CM KUKIS DL SHEN S LAMBORN KR MIERS LA KROGER LA DENARDO GL
Citation: Sj. Denardo et al., SYNERGISTIC THERAPY FOR BREAST-CANCER - DEVELOPMENT OF A CLINICAL PROTOCOL FOR RIT AND TAXOL BASED ON CURATIVE THERAPY OF XENOGRAFTED TUMORS AND Y-90 CHL6 PATIENT DOSIMETRY, The Journal of nuclear medicine, 39(5), 1998, pp. 1083-1083

Authors: DENARDO SJ KUKIS DL MIERS LA WINTHROP MD KROGER LA SALAKO Q SHEN S LAMBORN KR GUMERLOCK PH MEARES CF DENARDO GL
Citation: Sj. Denardo et al., YTTRIUM-90-DOTA-PEPTIDE CHIMERIC L6 RADIOIMMUNOCONJUGATE - EFFICACY AND TOXICITY IN MICE BEARING P53 MUTANT HUMAN BREAST-CANCER XENOGRAFTS, The Journal of nuclear medicine, 39(5), 1998, pp. 842-849

Authors: GUO JH ZHU ZM DENG WM SHEN S
Citation: Jh. Guo et al., ANGLE MEASUREMENT USING SURFACE-PLASMON-RESONANCE HETERODYNE INTERFEROMETRY - A NEW METHOD, Optical engineering, 37(11), 1998, pp. 2998-3001

Authors: LIU DX SHEN S XU HY WANG SF
Citation: Dx. Liu et al., PROTEOLYTIC MAPPING OF THE CORONAVIRUS INFECTIOUS-BRONCHITIS VIRUS 1B-POLYPROTEIN - EVIDENCE FOR THE PRESENCE OF 4 CLEAVAGE SITES OF THE 3C-LIKE PROTEINASE AND IDENTIFICATION OF 2 NOVEL CLEAVAGE PRODUCTS, Virology (New York, N.Y. Print), 246(2), 1998, pp. 288-297

Authors: SHEN S BOURREAU JP
Citation: S. Shen et Jp. Bourreau, ROLE OF EFFICACY OF MUSCARINIC STIMULATION IN CONTROLLING THE MODE OFEXCITATION-CONTRACTION COUPLING IN SMOOTH-MUSCLE, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 392-392

Authors: WURREY CJ SHEN S ZHU X ZHEN H DURIG JR
Citation: Cj. Wurrey et al., CONFORMATIONAL STUDIES OF CYANOMETHYLCYCLOPROPANE FROM TEMPERATURE-DEPENDENT FT-IR SPECTRA OF XENON SOLUTIONS AND AB-INITIO CALCULATIONS, Journal of molecular structure, 449(2-3), 1998, pp. 203-217

Authors: KAHARABATA SK SCHUEPP PH OGUNJEMIYO S SHEN S LECLERC MY DESJARDINS RL MACPHERSON JI
Citation: Sk. Kaharabata et al., FOOTPRINT CONSIDERATIONS IN BOREAS, J GEO RES-A, 102(D24), 1997, pp. 29113-29124

Authors: LAMBORN KR DENARDO GL DENARDO SJ GOLDSTEIN DS SHEN S LARKIN EC KROGER LA
Citation: Kr. Lamborn et al., TREATMENT-RELATED PARAMETERS PREDICTING EFFICACY OF LYM-1 RADIOIMMUNOTHERAPY IN PATIENTS WITH B-LYMPHOCYTIC MALIGNANCIES, Clinical cancer research, 3(8), 1997, pp. 1253-1260

Authors: DENARDO GL KUKIS DL SHEN S MAUSNER LF MEARES CF SRIVASTAVA SC MIERS LA DENARDO SJ
Citation: Gl. Denardo et al., EFFICACY AND TOXICITY OF CU-67-2IT-BAT-LYM-1 RADIOIMMUNOCONJUGATE IN MICE IMPLANTED WITH HUMAN BURKITTS-LYMPHOMA (RAJI), Clinical cancer research, 3(1), 1997, pp. 71-79

Authors: SMITH BA HALE JR ZHUKOVSKY A MICHAEL PC MINERVINI JV OLMSTEAD MM DEKOW GL ROSATI J CAMILLE RJ GUNG CY GWINN D SILVA F FAIRFAX SA SHEN S KNOOPERS HG WESSEL S KROOSHOOP HJG SHEVCHENKO OA GODEKE A TENKATE HHJ
Citation: Ba. Smith et al., PTF, A NEW FACILITY FOR PULSE FIELD TESTING OF LARGE-SCALE SUPERCONDUCTING CABLES AND JOINTS, IEEE transactions on applied superconductivity, 7(2), 1997, pp. 1049-1052

Authors: ECELBARGER CA FERNANDEZLLAMA P LEE AJ NIELSEN S WARE JA SHEN S POHL LR KNEPPER MA
Citation: Ca. Ecelbarger et al., ENHANCEMENT OF URINARY CONCENTRATING ABILITY BY CYCLOOXYGENASE INHIBITORS IS ASSOCIATED WITH INCREASED EXPRESSION OF NA-K-2CL COTRANSPORTERAND INCREASED TRAFFICKING OF AQUAPORIN-2 WATER CHANNEL, Journal of the American Society of Nephrology, 8, 1997, pp. 1913-1913

Authors: YANG XX SHEN S KUANG ZB
Citation: Xx. Yang et al., THE DEGENERATE SOLUTION FOR PIEZOTHERMOELASTIC MATERIALS, European journal of mechanics. A, Solids, 16(5), 1997, pp. 779-793

Authors: SHEN S DENARDO GL MACEY DJ ODONNELL RT YUAN A DENARDO DA DENARDO SJ
Citation: S. Shen et al., PRACTICAL DETERMINATION OF ORGAN S-VALUE FOR INDIVIDUAL PATIENTS FOR THERAPY, Nuclear medicine and biology, 24(5), 1997, pp. 447-449
Risultati: 1-25 | 26-50 | 51-75 | 76-96